Health Care • Biotechnology: Pharmaceutical Preparations
$32.33 ▲ +0.25
(+0.78%)
MKT CAP: $2.13B • VOL: 246.0K
52W L $26 52W H $36
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$27
MEDIAN
$36
MEAN
$37
HIGH
$44
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE LKFT TAPE
LKFT // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $39.12 | $37.18 | 2025-02-14 | $29.42 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $40.74 | $38.15 | 2025-02-06 | $30.39 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $36.86 | $35.56 | 2025-01-29 | $31.04 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $32.98 | — | 2025-01-17 | $31.68 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $28.45 | $30.71 | 2025-01-09 | $28.77 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $38.47 | $33.62 | 2024-12-18 | $28.13 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $31.36 | $32.65 | 2024-12-04 | $30.07 | -4.3% | 48% | C |